Consolidated Statements of Cash Flows - USD ($)
$ in Thousands |
3 Months Ended |
12 Months Ended |
Mar. 28, 2015 |
Mar. 29, 2014 |
Dec. 27, 2014 |
Dec. 28, 2013 |
Dec. 29, 2012 |
| Cash flow from operating activities: |
|
|
|
|
|
| Net loss |
$ (79,837)
|
$ (53,068)
|
$ (6,282)
|
$ (103,679)
|
$ (50,577)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
| Depreciation, depletion, amortization and accretion |
27,358
|
20,789
|
95,211
|
75,927
|
72,179
|
| Net interest expense |
982
|
850
|
252
|
3,256
|
3,266
|
| Share-based compensation expense |
15,217
|
566
|
2,235
|
2,315
|
2,533
|
| Deferred income tax benefit |
|
(525)
|
(5,927)
|
(4,408)
|
(3,468)
|
| Net (gain) loss on asset disposals |
(1,834)
|
(48)
|
6,500
|
12,419
|
2,564
|
| Goodwill impairment |
|
|
|
68,202
|
|
| Loss on debt financings |
688
|
|
|
2,989
|
9,469
|
| Other |
780
|
558
|
(957)
|
(1,098)
|
(874)
|
| Decrease (increase) in operating assets, net of acquisitions: |
|
|
|
|
|
| Accounts receivable, net |
30,309
|
16,989
|
(10,366)
|
9,884
|
5,201
|
| Inventories |
(21,413)
|
(13,377)
|
(3,735)
|
499
|
(1,726)
|
| Costs and estimated earnings in excess of billings |
(1,662)
|
(839)
|
1,359
|
196
|
6,931
|
| Other current assets |
(303)
|
9
|
(3,997)
|
(453)
|
3,494
|
| Other assets |
755
|
3,202
|
4,767
|
(1,708)
|
1,189
|
| (Decrease) increase in operating liabilities, net of acquisitions: |
|
|
|
|
|
| Accounts payable |
(10,045)
|
(10,239)
|
(6,455)
|
4,067
|
(6,076)
|
| Accrued expenses |
(20,669)
|
(9,620)
|
13,162
|
(742)
|
17,175
|
| Billings in excess of costs and estimated earnings |
(649)
|
(2,728)
|
(305)
|
1,998
|
2,589
|
| Other liabilities |
(203)
|
(2,044)
|
(6,373)
|
(3,252)
|
(1,590)
|
| Net cash used in operating activities |
(61,508)
|
(50,375)
|
79,089
|
66,412
|
62,279
|
| Cash flow from investing activities: |
|
|
|
|
|
| Acquisitions, net of cash acquired |
|
(182,514)
|
(397,854)
|
(61,601)
|
(48,757)
|
| Purchases of property, plant and equipment |
(17,708)
|
(19,941)
|
(76,162)
|
(65,999)
|
(45,488)
|
| Proceeds from the sale of property, plant and equipment |
2,741
|
2,202
|
13,366
|
16,085
|
8,836
|
| Other |
(276)
|
7
|
(630)
|
|
69
|
| Net cash used for investing activities |
(15,243)
|
(200,246)
|
(461,280)
|
(111,515)
|
(85,340)
|
| Cash flow from financing activities: |
|
|
|
|
|
| Proceeds from initial public offering |
460,000
|
|
|
|
|
| Capital issuance costs |
(35,956)
|
|
|
|
|
| Capital contributions by partners |
|
24,350
|
24,350
|
|
|
| Proceeds from debt issuances |
104,000
|
306,750
|
762,250
|
234,681
|
726,442
|
| Payments on long-term debt |
|
|
(389,270)
|
(188,424)
|
(697,438)
|
| Debt issuance costs |
(4,055)
|
(6,309)
|
|
|
|
| Payments on debt |
(106,441)
|
(54,314)
|
|
|
|
| Purchase of noncontrolling interest in consolidated subsidiary |
(35,000)
|
|
|
|
|
| Payments on acquisition-related liabilities |
(4,032)
|
(638)
|
(10,935)
|
(9,801)
|
(7,519)
|
| Financing costs |
|
|
(9,085)
|
(3,864)
|
(13,081)
|
| Other |
|
|
(88)
|
(3)
|
(702)
|
| Net cash provided by (used for) financing activities |
378,516
|
269,839
|
377,222
|
32,589
|
7,702
|
| Net increase in cash |
301,765
|
19,218
|
(4,969)
|
(12,514)
|
(15,359)
|
| Cash - Beginning of period |
13,215
|
18,184
|
18,184
|
30,698
|
46,057
|
| Cash - end of period |
$ 314,980
|
$ 37,402
|
$ 13,215
|
$ 18,184
|
$ 30,698
|